NCT06108297View on ClinicalTrials.gov

Lithium Long COVID Dose-finding Study

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

March 26, 2024

Study Completion Date

May 2, 2024

Conditions
Long COVID
Interventions
DIETARY_SUPPLEMENT

Lithium

Elemental lithium as lithium aspartate.

Trial Locations (1)

14221

UBMD Neurology, Williamsville

All Listed Sponsors
lead

State University of New York at Buffalo

OTHER

NCT06108297 - Lithium Long COVID Dose-finding Study | Biotech Hunter | Biotech Hunter